This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Harvard College, Zikani Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,071 
1 out of 1 Years Active: 2026
Title: Philip Hogan: Innovator in Macrolide Research
Introduction
Philip Hogan is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of macrolide antibiotics. His work focuses on innovative solutions for treating infectious diseases.
Latest Patents
Hogan holds a patent for "C10-alkylene substituted 13-membered macrolides and uses thereof." This patent describes 13-membered macrolides that are specifically designed for the treatment of infectious diseases. The macrolides detailed in his patent are azaketolides, which are effective against Gram-negative bacteria. The patent also outlines methods for preparing these macrolides, pharmaceutical compositions that include them, and their application in treating various infections.
Career Highlights
Throughout his career, Philip Hogan has worked with prominent organizations, including Zikani Therapeutics, Inc. and Harvard College. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hogan has collaborated with esteemed colleagues such as Ziyang Zhang and Richard Alm. These partnerships have further enriched his research endeavors and have led to advancements in the field of macrolide antibiotics.
Conclusion
Philip Hogan's innovative work in the development of macrolide antibiotics showcases his commitment to addressing critical health challenges. His contributions are vital in the ongoing fight against infectious diseases.